Abela Pharm
Abela Pharm is a Serbian pharmaceutical company that researches, manufactures, and markets natural dietary supplements, probiotics, and pharmaceutical products across gastroenterology, cardiology, allergy, and related therapeutic areas, distributing through pharmacy networks in 19+ countries and serving healthcare professionals and consumers globally.
- Company typePrivate
- Founded2001
- HeadquartersBelgrade
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Abela Pharm does
Abela Pharm d.o.o. is a Serbian pharmaceutical company headquartered in Belgrade that researches, develops, manufactures, and markets natural dietary supplements, medical devices, and pharmaceutical products, with a core specialization in probiotics. The company's portfolio spans eleven therapeutic categories including gastroenterology (Bulardi, BebiCol Forte, EnteroBiotik, Flobian), pulmonology (PropoMucil), cardiology (ARTEROprotect, CardioVitamin), bone health (K2D3 VIVA), allergy (Immuno GD-Poly), urinary tract health (Naturoplex), men's health (Afrička Šljiva), and weight management (Herbafast), plus the prescription proton pump inhibitor Rabezol. The underlying technology platform centers on proprietary probiotic strain R&D — anchored by the 1,600 m2 Probiotic Excellence Center research facility — and the @TECH packaging system, a multi-layer laminate sachet with inert gas filling that guarantees probiotic cell count at end of shelf life rather than only at production. The company operates three GMP-certified manufacturing facilities in Serbia (Belgrade producing 7M+ packages annually, Stari Banovci, and Barice with 20M pharmaceutical unit capacity annually, the latter two acquired from STADA and Alvogen in 2019).
The business model is consumer health-focused, selling primarily through pharmacy distribution networks across Serbia and export markets spanning 19+ countries in Europe, the Middle East, North Africa, and Southeast Asia (Singapore entry realized March 2025), reaching an addressable population of over 400 million people. Go-to-market is sales-led and built around engagement with healthcare professionals — pediatricians, gastroenterologists, and pharmacists — through annual scientific symposiums (300-500+ attendees), CME-accredited training sessions, peer-reviewed publications (20+ clinical studies), and educational content via the Probiotic Excellence Center. Pricing is not publicly disclosed; products are positioned as premium, scientifically-backed natural supplements and pharmaceuticals differentiated by clinical evidence, packaging innovation, and European GMP certification enabling cross-border distribution. The company is privately held, led by General Director Davor J. Korčok (11+ years) with Scientific Director Krešimir Gjuračić overseeing probiotic research.
Abela Pharm firmographics
Firmographics- Name
- Abela Pharm
- Legal name
- Abela Pharm d.o.o.
- Website
- https://abelapharm.rs
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Abela Pharm is a Serbian pharmaceutical company that researches, manufactures, and markets natural dietary supplements, probiotics, and pharmaceutical products across gastroenterology, cardiology, allergy, and related therapeutic areas, distributing through pharmacy networks in 19+ countries and serving healthcare professionals and consumers globally.
- Ownership category
- akta.pro rank
Abela Pharm industry classification
Industry- Product category
- Dietary Supplements and Pharmaceutical Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Multivitamins & Daily Packs (CRADAGAC)
- akta.pro secondary industries
- Vitamins & Minerals (Single Nutrients) (CRADAGAB), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
Keywords
Where Abela Pharm is headquartered
LocationHeadquarters
- HQ city
- Belgrade
Offices4 records
Markets served
Abela Pharm business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Dietary Supplements: Production and sale of natural dietary supplements including probiotics (Bulardi, Bebicol, Probiotik EnteroBiotik), vitamins and minerals (BiVits ACTIVA), weight management (Herbafast), and other health products sold through pharmacy networks.
- Pharmaceutical Products: Following acquisition of GMP-certified manufacturing facilities from STADA and Alvogen, the company expanded into production of pharmaceutical drugs including Rabezol (proton pump inhibitor) and other medicinal products.
- Medical Devices: Production of medical devices including probiotic preparations and related healthcare products.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Abela Pharm product offering
Product offeringCore offering
AbelaPharm develops, manufactures, and markets natural dietary supplements, probiotics, vitamins, herbal preparations, medical devices, and pharmaceutical drugs across 11 therapeutic categories. The company operates three GMP-certified production facilities in Serbia and sells its branded products through pharmacy chains domestically and through local distributors in 19+ export countries reaching more than 400 million consumers.
Product overview
AbelaPharm is a Serbian pharmaceutical company focused on research, development, and manufacturing of completely natural dietary supplements, medical devices, and pharmaceutical products. The portfolio is organized across 11 therapeutic categories: Pulmonology/ORL (PropoMucil), Gastroenterology (Bulardi, BebiCol Forte, Bebicol, EnteroBiotik, Flobian), Bones/Joints/Muscles (Tensilen, K2D3 VIVA), Cardiology (ARTEROprotect, CardioVitamin), Vitamins & Minerals (BiVits ACTIVA), Mood (single product), Dermatology, Urinary Tract (Naturoplex, Naturoplex Brusnica), Allergy (Immuno GD-Poly), Men's Health (Afrička Šljiva, Afrička Šljiva FORTE, Kapi Afričke Šljive), and Weight Management (Herbafast Lady, Herbafast Fiber, Herbafast Detox, Herbafast Avantgarde). The company also manufactures the proton pump inhibitor drug Rabezol and operates the Probiotic Excellence Center for scientific research and education. The proprietary @TECH packaging technology is a key innovation ensuring probiotic stability. Products are exported to 19 countries, reaching over 400 million people in the EU, Middle East, America, and Africa.
Differentiator
Problem solved
Functional benefit
Brands
- Herbafast: Product line for weight management with 18 years of experience, includes Herbafast Lady, Herbafast Gentleman, Herbafast Fiber, Herbafast Detox, and Herbafast Avantgarde Mineral Biotic
- Bulardi
- PropoMucil
- Naturoplex
- Probiotic Excellence Center
- Afrička Šljiva
- Immuno GD-Poly
- BiVits
- Flobian
- Probiotik EnteroBiotik
- Rabezol
Products and services
- Bulardi Flagship probiotic supplement containing Saccharomyces boulardii, available in multiple formulations (capsules, junior, Flobian). Used for prevention and treatment of antibiotic-associated diarrhea, traveler's diarrhea, and other digestive conditions. The probiotic yeast can be taken simultaneously with antibiotics.
- BebiCol Forte
Quantifiable outcome
- Guaranteed probiotic cell count at end of shelf life (not just at production), unlike products that only declare counts at manufacturing
- +5 more outcomes
Companies that use Abela Pharm
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Abela Pharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Abela Pharm partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition)coreProbiotic Excellence Center partners with ESPGHAN for scientific exchange and education. ESPPGHAN presidents and leading experts participate in AbelaPharm-organized symposiums, presenting latest guidelines on probiotic use in children.
- EAGEN (European Association for Gastroenterology, Endoscopy and Nutrition)coreEAGEN marked 53 years of activity with a symposium in Belgrade organized with Probiotic Excellence Center as partner. Five EAGEN presidents participated, presenting latest European guidelines for digestive disease treatment.
- ACIESBiocoreBiotechnological company with which Probiotic Excellence Center researchers examined the resistance of Lactobacillus plantarum strains to acidic environment and stress caused by high pH values.
- University of Belgrade Faculty of PharmacycoreAbelaPharm is a scientific-teaching base for pharmacy and technology students. PhD, specialist, and graduate theses have been developed at the Probiotic Excellence Center. Students present research at international congresses.
- Medical Faculty KragujevaccoreProbiotic Excellence Center opened for pharmacy students from the Medical Faculty in Kragujevac, providing practical knowledge in probiotic production, research, and quality control. Partnership with Faculty Dean Prof. Dr Vladimir Jakovljević.
- Savez medicinskih sestara predškolskih ustanova Srbije (Union of Medical Nurses of Preschool Institutions of Serbia)coreCollaboration on educational programs for parents and kindergarten staff on gut flora, immunity, and preventive health. Jointly published 'Guide for Preschool Age' and allergy guides through a 3-year educational workshop program.
- Udruženje Treće doba (Third Age Association)minorPartnership for World Osteoporosis Day event where AbelaPharm organized bone density screenings for elderly members of the association.
- Pro-femina ConferenceminorAbelaPharm participated in the 9th Pro-femina conference organized for World Menopause Day, with a panel on osteoporosis prevention.
- Harvard Medical CommunityminorProbiotic Excellence Center references Harvard research on gut microbiota and leaky gut syndrome. Scientific director Dr. Krešimir Gjuračić maintains connections with leading international researchers in the probiotic field.
- Medical Faculty NišminorProbiotic Excellence Center conducted the 'Probiotics from Industry to Digestive Tract' project at the Medical Faculty in Niš, enhancing knowledge and competencies of future professionals.
- Fondacija Nataša KovačevićminorCharitable partnership for the 'Take Health Into Your Own Hands, Let All Children Jump' campaign providing dynamic prosthetics for children. AbelaPharm donated 1,447,860 dinars — 1 RSD per box of BiVits ACTIVA sold between Dec 2021 and April 2022.
- STADA Group (Germany)coreAbelaPharm acquired a pharmaceutical manufacturing factory in Stari Banovci from German STADA Group in April 2019 for over 4 million euros. This represents a strategic acquisition enabling pharmaceutical drug manufacturing alongside dietary supplements.
- Alvogen (USA)coreAbelaPharm acquired a pharmaceutical manufacturing facility in Barice, near Vršac, from American company Alvogen. The modern GMP-certified facility was built in 2011 and provides capacity for 20 million pharmaceutical units per year.
Scale indicators18 records
Recent moves6 records
Expansion highlights6 records
Abela Pharm competitors and assessment
Company assessmentBroad incumbents
- STADA Arzneimittel: German generics and consumer health company from which AbelaPharm acquired its Stari Banovci factory in 2019. Comparable as a European-focused generics and OTC manufacturer operating in the same regulatory and channel environment AbelaPharm is now targeting.
- Chr. Hansen (Novonesis): Global bioscience company (now Novonesis post-merger with Novozymes) supplying probiotic strains, cultures, and enzymes to dietary supplement and dairy customers worldwide. Comparable as a science-backed probiotic supplier, though primarily B2B and far larger.
- Alvogen: US-headquartered generics and pharmaceutical manufacturer whose Barice factory AbelaPharm acquired in 2019. Comparable as a generics and OTC player with European manufacturing footprint and a customer overlap with AbelaPharm's pharmaceutical ambitions.
- Yakult Honsha: Global probiotic beverage and supplement giant with Lactobacillus casei strain products distributed in 40+ countries. Comparable as a category-defining incumbent in probiotics, though much larger and brand-led versus AbelaPharm's science-led pharmacy positioning.
Direct peers
- BioGaia: Swedish probiotic R&D and marketing company specializing in Lactobacillus reuteri strains, sold globally through pharmacy and consumer health channels. Most directly comparable peer given probiotic focus, similar pharmacy-led distribution, and clinical evidence-driven positioning.
- Winclove Probiotics: Dutch probiotic manufacturer focused on multi-strain and indication-specific formulations sold through pharmacies and healthcare professionals in Europe. Comparable in clinical evidence emphasis, pharmacy distribution, and indication-specific positioning (e.g., pediatric, GI).
- Lallemand Health Solutions: Canadian probiotic manufacturer producing Saccharomyces boulardii (the same yeast that anchors AbelaPharm's flagship Bulardi product) and other microbial solutions for human health. Closest direct competitor in the S. boulardii space and a benchmark for probiotic contract manufacturing.
- Probi AB: Swedish probiotic company developing and commercializing probiotic strains (including Lactobacillus plantarum 299v, the same strain used in AbelaPharm's Flobian). Direct competitor in documented probiotic strains and B2B/B2C probiotic commercialization.
Peers
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Abela Pharm social profiles
Digital presenceAbela Pharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Abela Pharm leadership team
Management profileNumber of profiles
Profiles3 records
Abela Pharm subsidiaries and ownership
Company hierarchySubsidiaries3 records
Abela Pharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Abela Pharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Abela Pharm
What does Abela Pharm do?
AbelaPharm develops, manufactures, and markets natural dietary supplements, probiotics, vitamins, herbal preparations, medical devices, and pharmaceutical drugs across 11 therapeutic categories. The company operates three GMP-certified production facilities in Serbia and sells its branded products through pharmacy chains domestically and through local distributors in 19+ export countries reaching more than 400 million consumers.
Is Abela Pharm a public or private company?
Abela Pharm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Abela Pharm founded?
Abela Pharm was founded in 2001. It employs 11 to 50 people.
Where is Abela Pharm based?
Abela Pharm is headquartered in Belgrade.
How does Abela Pharm make money?
Three revenue lines are on record. Dietary Supplements are the primary driver. The others are pharmaceutical Products and medical Devices.
Who are Abela Pharm's main competitors?
Broad incumbents on record are STADA Arzneimittel, Chr. Hansen (Novonesis), Alvogen and Yakult Honsha. Direct peers are BioGaia, Winclove Probiotics, Lallemand Health Solutions and Probi AB. Danone (Medical Nutrition) is listed as a peer.
Does Abela Pharm have an API?
No public API is recorded for Abela Pharm.
What industry is Abela Pharm in?
Abela Pharm's product category is Dietary Supplements and Pharmaceutical Manufacturing. Its primary akta.pro industry code is CRADAGAC, Multivitamins & Daily Packs, with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 325411 and its SIC code is 2833.